Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars in millions, except per share amounts) (Unaudited) | |||||||||||||||||||||||
Revenue | 2,366 | 2,167 | 9,173 | 8,475 | |||||||||||||||||||
Income from Continuing Operations2 | 6.8 | 29.6 | 127.9 | 172.3 | |||||||||||||||||||
Net Income (Loss) | 6.0 | (31.6) | 82.0 | 143.4 | |||||||||||||||||||
Net (Loss) Income attributable to Dole plc | (2.7) | (39.1) | 51.3 | 125.5 | |||||||||||||||||||
Diluted EPS from Continuing Operations | (0.02) | 0.23 | 1.01 | 1.62 | |||||||||||||||||||
Diluted EPS | (0.03) | (0.41) | 0.53 | 1.32 | |||||||||||||||||||
Adjusted EBITDA1 | 72.7 | 74.6 | 395.4 | 392.2 | |||||||||||||||||||
Adjusted Net Income1 | 13.8 | 15.3 | 115.0 | 120.9 | |||||||||||||||||||
Adjusted Diluted EPS1 | 0.14 | 0.16 | 1.20 | 1.27 | |||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
(U.S. Dollars in thousands) (unaudited) | |||||||||||||||||||||||
Revenue | Adjusted EBITDA1 | Revenue | Adjusted EBITDA1 | ||||||||||||||||||||
Fresh Fruit | $ | 874,036 | $ | 26,602 | $ | 819,066 | $ | 31,890 | |||||||||||||||
Diversified Fresh Produce - EMEA | 1,025,887 | 32,597 | 910,604 | 32,487 | |||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 486,455 | 13,468 | 463,285 | 10,234 | |||||||||||||||||||
Intersegment | (20,216) | — | (25,491) | — | |||||||||||||||||||
Total | $ | 2,366,162 | $ | 72,667 | $ | 2,167,464 | $ | 74,611 | |||||||||||||||
Year Ended | |||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
(U.S. Dollars in thousands) (unaudited) | |||||||||||||||||||||||
Revenue | Adjusted EBITDA1 | Revenue | Adjusted EBITDA1 | ||||||||||||||||||||
Fresh Fruit | $ | 3,615,127 | $ | 189,842 | $ | 3,293,527 | $ | 214,848 | |||||||||||||||
Diversified Fresh Produce - EMEA | 4,016,573 | 149,981 | 3,608,692 | 131,504 | |||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 1,656,207 | 55,553 | 1,686,281 | 45,851 | |||||||||||||||||||
Intersegment | (115,000) | — | (113,157) | — | |||||||||||||||||||
Total | $ | 9,172,907 | $ | 395,376 | $ | 8,475,343 | $ | 392,203 | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
Revenue, net | $ | 2,366,161 | $ | 2,167,464 | $ | 9,172,907 | $ | 8,475,343 | |||||||||||||||
Cost of sales | (2,207,527) | (2,009,045) | (8,458,599) | (7,757,622) | |||||||||||||||||||
Gross profit | 158,634 | 158,419 | 714,308 | 717,721 | |||||||||||||||||||
Selling, marketing, general and administrative expenses | (129,135) | (122,675) | (495,476) | (474,058) | |||||||||||||||||||
Gain on disposal of businesses | 54 | 472 | 606 | 76,417 | |||||||||||||||||||
Gain on asset sales | 1,079 | 747 | 15,045 | 2,648 | |||||||||||||||||||
Impairment of goodwill | — | — | — | (36,684) | |||||||||||||||||||
Impairment and asset write-downs of property, plant and equipment and lease assets | (2,942) | (2,154) | (11,518) | (5,480) | |||||||||||||||||||
Operating income | 27,690 | 34,809 | 222,965 | 280,564 | |||||||||||||||||||
Other income (expense), net | 4,876 | 11,137 | (1,574) | 20,595 | |||||||||||||||||||
Interest income | 3,900 | 2,410 | 13,373 | 10,745 | |||||||||||||||||||
Interest expense | (15,202) | (18,055) | (66,541) | (72,264) | |||||||||||||||||||
Income from continuing operations before income taxes and equity earnings | 21,264 | 30,301 | 168,223 | 239,640 | |||||||||||||||||||
Income tax expense | (21,821) | (264) | (71,003) | (75,649) | |||||||||||||||||||
Equity method earnings (loss) | 7,362 | (403) | 30,714 | 8,308 | |||||||||||||||||||
Income from continuing operations | 6,805 | 29,634 | 127,934 | 172,299 | |||||||||||||||||||
Loss from discontinued operations, net of income taxes | (803) | (61,231) | (45,959) | (28,880) | |||||||||||||||||||
Net income (loss) | 6,002 | (31,597) | 81,975 | 143,419 | |||||||||||||||||||
Less: Net income attributable to noncontrolling interests | (8,666) | (7,552) | (30,656) | (17,906) | |||||||||||||||||||
Net (loss) income attributable to Dole plc | $ | (2,664) | $ | (39,149) | $ | 51,319 | $ | 125,513 | |||||||||||||||
Income (loss) per share - basic: | |||||||||||||||||||||||
Continuing operations | $ | (0.02) | $ | 0.23 | $ | 1.02 | $ | 1.63 | |||||||||||||||
Discontinued operations | (0.01) | (0.64) | (0.48) | (0.31) | |||||||||||||||||||
Net (loss) income per share attributable to Dole plc - basic | $ | (0.03) | $ | (0.41) | $ | 0.54 | $ | 1.32 | |||||||||||||||
Income (loss) per share - diluted: | |||||||||||||||||||||||
Continuing operations | $ | (0.02) | $ | 0.23 | $ | 1.01 | $ | 1.62 | |||||||||||||||
Discontinued operations | (0.01) | (0.64) | (0.48) | (0.30) | |||||||||||||||||||
Net (loss) income per share attributable to Dole plc - diluted | $ | (0.03) | $ | (0.41) | $ | 0.53 | $ | 1.32 | |||||||||||||||
Weighted-average shares: | |||||||||||||||||||||||
Basic | 95,163 | 95,019 | 95,145 | 94,967 | |||||||||||||||||||
Diluted | 96,104 | 95,702 | 95,902 | 95,471 | |||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
ASSETS | (U.S. Dollars and shares in thousands) | ||||||||||
Cash and cash equivalents | $ | 267,854 | $ | 330,017 | |||||||
Short-term investments | 6,418 | 6,019 | |||||||||
Trade receivables, net of allowances for credit losses of $20,558 and $19,493, respectively | 539,840 | 473,511 | |||||||||
Grower advance receivables, net of allowances of $37,915 and $29,304, respectively | 143,426 | 104,956 | |||||||||
Other receivables, net of allowances of $17,027 and $15,248, respectively | 121,355 | 125,951 | |||||||||
Inventories, net of allowances of $3,659 and $4,178, respectively | 509,260 | 430,168 | |||||||||
Prepaid expenses | 70,007 | 68,918 | |||||||||
Other current assets | 17,891 | 15,111 | |||||||||
Fresh Vegetables current assets held for sale | — | 281,990 | |||||||||
Assets held for sale | 75,689 | 1,419 | |||||||||
Total current assets | 1,751,740 | 1,838,060 | |||||||||
Long-term investments | 13,827 | 14,630 | |||||||||
Investments in unconsolidated affiliates | 142,082 | 129,322 | |||||||||
Actively marketed property | 53,231 | 45,778 | |||||||||
Property, plant and equipment, net of accumulated depreciation of $619,706 and $502,062, respectively | 1,081,656 | 1,120,366 | |||||||||
Operating lease right-of-use assets | 371,366 | 341,722 | |||||||||
Goodwill | 434,345 | 429,590 | |||||||||
DOLE® brand | 306,280 | 306,280 | |||||||||
Other intangible assets, net of accumulated amortization of $133,022 and $118,956, respectively | 18,997 | 25,238 | |||||||||
Other assets | 133,931 | 112,893 | |||||||||
Deferred tax assets, net | 88,669 | 82,484 | |||||||||
Total assets | $ | 4,396,124 | $ | 4,446,363 | |||||||
LIABILITIES AND EQUITY | |||||||||||
Accounts payable | $ | 712,483 | $ | 648,591 | |||||||
Income taxes payable | 21,805 | 42,753 | |||||||||
Accrued liabilities | 517,989 | 443,145 | |||||||||
Bank overdrafts | 9,611 | 11,443 | |||||||||
Current portion of long-term debt, net | 57,668 | 80,097 | |||||||||
Current maturities of operating leases | 71,379 | 64,357 | |||||||||
Payroll and other tax | 36,320 | 28,056 | |||||||||
Contingent consideration | 3,252 | 3,399 | |||||||||
Pension and postretirement benefits | 18,699 | 18,491 | |||||||||
Fresh Vegetables current liabilities held for sale | — | 214,387 | |||||||||
Liabilities held for sale | 14,047 | — | |||||||||
Dividends payable and other current liabilities | 31,228 | 14,696 | |||||||||
Total current liabilities | 1,494,481 | 1,569,415 | |||||||||
Long-term debt, net | 799,814 | 866,075 | |||||||||
Operating leases, less current maturities | 306,566 | 280,896 | |||||||||
Deferred tax liabilities, net | 90,100 | 84,712 | |||||||||
Income taxes payable, less current portion | — | 6,210 | |||||||||
Contingent consideration, less current portion | 500 | 4,007 | |||||||||
Pension and postretirement benefits, less current portion | 135,900 | 129,870 | |||||||||
Other long-term liabilities | 66,990 | 70,260 | |||||||||
Total liabilities | $ | 2,894,351 | $ | 3,011,445 | |||||||
Redeemable noncontrolling interests | 29,716 | 35,554 | |||||||||
Stockholders’ equity: | |||||||||||
Common stock — $0.01 par value; 300,000 shares authorized and 95,163 and 95,041 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | 952 | 950 | |||||||||
Additional paid-in capital | 804,247 | 801,099 | |||||||||
Retained earnings | 676,371 | 657,430 | |||||||||
Accumulated other comprehensive loss | (117,467) | (166,180) | |||||||||
Total equity attributable to Dole plc | 1,364,103 | 1,293,299 | |||||||||
Equity attributable to noncontrolling interests | 107,954 | 106,065 | |||||||||
Total equity | 1,472,057 | 1,399,364 | |||||||||
Total liabilities, redeemable noncontrolling interests and equity | $ | 4,396,124 | $ | 4,446,363 | |||||||
Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
Operating Activities | (U.S. Dollars in thousands) | ||||||||||
Net income | $ | 81,975 | $ | 143,419 | |||||||
Loss from discontinued operations, net of income taxes | 45,959 | 28,880 | |||||||||
Income from continuing operations | 127,934 | 172,299 | |||||||||
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: | |||||||||||
Depreciation and amortization | 112,661 | 98,818 | |||||||||
Impairment of goodwill | — | 36,684 | |||||||||
Impairment and asset write-downs of property, plant and equipment and lease assets | 11,518 | 5,480 | |||||||||
Net gain on sale of assets | (15,045) | (2,648) | |||||||||
Net gain on sale of businesses | (606) | (76,417) | |||||||||
Net loss (gain) on financial instruments | 20,308 | (12,397) | |||||||||
Stock-based compensation expense | 6,854 | 7,951 | |||||||||
Equity method earnings | (30,714) | (8,308) | |||||||||
Amortization of debt discounts and debt issuance costs | 4,127 | 7,746 | |||||||||
Deferred tax expense (benefit) | 12,975 | (17,588) | |||||||||
Pension and other postretirement benefit plan expense | 7,485 | 5,404 | |||||||||
Dividends received from equity method investees | 12,688 | 7,049 | |||||||||
Gain on insurance proceeds | (17,447) | — | |||||||||
Other | 363 | (247) | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Receivables, net of allowances | (124,817) | (20,603) | |||||||||
Inventories | (67,998) | (70,810) | |||||||||
Prepaids, other current assets and other assets | 2,692 | (281) | |||||||||
Accounts payable, accrued liabilities and other liabilities | 60,228 | 130,589 | |||||||||
Net cash provided by operating activities - continuing operations | 123,206 | 262,721 | |||||||||
Investing Activities | |||||||||||
Sales of assets | 13,645 | 5,011 | |||||||||
Capital expenditures | (121,497) | (82,435) | |||||||||
Proceeds from sale of businesses, net of transaction costs and cash transferred | 68,621 | 117,935 | |||||||||
Insurance proceeds | 19,606 | 527 | |||||||||
Sales (purchases) of unconsolidated affiliates | 3,152 | (1,769) | |||||||||
Acquisitions, net of cash acquired | (2,248) | (926) | |||||||||
Other | (276) | (2,563) | |||||||||
Net cash (used in) provided by investing activities - continuing operations | (18,997) | 35,780 | |||||||||
Financing Activities | |||||||||||
Proceeds from borrowings and overdrafts | 1,838,112 | 1,517,106 | |||||||||
Repayments on borrowings and overdrafts and payment of debt refinancing fees | (1,926,927) | (1,696,130) | |||||||||
Dividends paid to shareholders | (31,568) | (30,551) | |||||||||
Dividends paid to noncontrolling interests and other noncontrolling interest activity, net | (28,076) | (26,703) | |||||||||
Payments of contingent consideration | (2,801) | (1,567) | |||||||||
Net cash used in financing activities - continuing operations | (151,260) | (237,845) | |||||||||
Effect of foreign currency exchange rate changes on cash | 17,724 | (15,241) | |||||||||
Net cash (used in) provided by operating activities - discontinued operations | (27,912) | 22,592 | |||||||||
Net cash used in investing activities - discontinued operations | (6,626) | (13,293) | |||||||||
Cash (used in) provided by discontinued operations, net | (34,538) | 9,299 | |||||||||
(Decrease) increase in cash and cash equivalents | (63,865) | 54,714 | |||||||||
Cash and cash equivalents at beginning of period, including discontinued operations | 331,719 | 277,005 | |||||||||
Cash and cash equivalents at end of period, including discontinued operations | $ | 267,854 | $ | 331,719 | |||||||
Supplemental cash flow information: | |||||||||||
Income tax payments, including discontinued operations, net of refunds | $ | (100,100) | $ | (77,967) | |||||||
Interest payments on borrowings | $ | (63,685) | $ | (67,397) | |||||||
Non-cash Investing and Financing Activities: | |||||||||||
Accrued property, plant and equipment | $ | (2,724) | $ | (2,983) | |||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||
Net income (loss) (Reported GAAP) | $ | 6,002 | $ | (31,597) | $ | 81,975 | $ | 143,419 | |||||||||||||||
Loss from discontinued operations, net of income taxes | 803 | 61,231 | 45,959 | 28,880 | |||||||||||||||||||
Income from continuing operations (Reported GAAP) | 6,805 | 29,634 | 127,934 | 172,299 | |||||||||||||||||||
Income tax expense | 21,821 | 264 | 71,003 | 75,649 | |||||||||||||||||||
Interest expense | 15,202 | 18,055 | 66,541 | 72,264 | |||||||||||||||||||
Mark to market (gains) losses | (3,316) | (11,356) | 18,753 | (10,139) | |||||||||||||||||||
Gain on asset sales | (1,076) | (90) | (12,254) | (125) | |||||||||||||||||||
Gain on disposal of businesses | (54) | (472) | (606) | (76,417) | |||||||||||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | (187) | (16,812) | (2,878) | |||||||||||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | 740 | 10,611 | 740 | |||||||||||||||||||
Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
Restructuring and costs for legal matters | 3,203 | 459 | 3,786 | 459 | |||||||||||||||||||
Debt refinancing expenses | — | — | 3,182 | — | |||||||||||||||||||
Other items1,2 | 801 | 11 | 1,115 | (7) | |||||||||||||||||||
Adjustments from equity method investments | 239 | 9,294 | 867 | 16,258 | |||||||||||||||||||
Adjusted EBIT (Non-GAAP) | 41,090 | 46,352 | 274,120 | 284,787 | |||||||||||||||||||
Depreciation | 27,228 | 24,410 | 105,559 | 91,262 | |||||||||||||||||||
Amortization of intangible assets | 1,788 | 1,776 | 7,102 | 7,556 | |||||||||||||||||||
Depreciation and amortization adjustments from equity method investments | 2,561 | 2,073 | 8,595 | 8,598 | |||||||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 72,667 | $ | 74,611 | $ | 395,376 | $ | 392,203 | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||||||||||
December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||
(U.S. Dollars and shares in thousands, except per share amounts) | |||||||||||||||||||||||
Net (loss) income attributable to Dole plc (Reported GAAP) | $ | (2,664) | $ | (39,149) | $ | 51,319 | $ | 125,513 | |||||||||||||||
Loss from discontinued operations, net of income taxes | 803 | 61,231 | 45,959 | 28,880 | |||||||||||||||||||
Income from continuing operations attributable to Dole plc | (1,861) | 22,082 | 97,278 | 154,393 | |||||||||||||||||||
Amortization of intangible assets | 1,788 | 1,776 | 7,102 | 7,556 | |||||||||||||||||||
Mark to market (gains) losses | (3,316) | (11,356) | 18,753 | (10,139) | |||||||||||||||||||
Gain on asset sales | (1,076) | (90) | (12,254) | (125) | |||||||||||||||||||
Gain on disposal of businesses | (54) | (472) | (606) | (76,417) | |||||||||||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | (187) | (16,812) | (2,878) | |||||||||||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | 740 | 10,611 | 740 | |||||||||||||||||||
Impairment of goodwill | — | — | — | 36,684 | |||||||||||||||||||
Restructuring and costs for legal matters | 3,203 | 459 | 3,786 | 459 | |||||||||||||||||||
Debt refinancing expenses | — | — | 3,182 | — | |||||||||||||||||||
Other items3,4 | 2,279 | 11 | 2,593 | (7) | |||||||||||||||||||
Adjustments from equity method investments | (2,955) | 7,926 | (10,115) | 9,708 | |||||||||||||||||||
Income tax on items above and discrete tax items | 17,338 | (5,338) | 12,846 | 13,162 | |||||||||||||||||||
NCI impact on items above | 978 | (271) | (1,324) | (12,239) | |||||||||||||||||||
Adjusted Net Income for Adjusted EPS calculation (Non-GAAP) | $ | 13,789 | $ | 15,280 | $ | 115,040 | $ | 120,897 | |||||||||||||||
Adjusted earnings per share – basic (Non-GAAP) | $ | 0.14 | $ | 0.16 | $ | 1.21 | $ | 1.27 | |||||||||||||||
Adjusted earnings per share – diluted (Non-GAAP) | $ | 0.14 | $ | 0.16 | $ | 1.20 | $ | 1.27 | |||||||||||||||
Weighted average shares outstanding – basic | 95,163 | 95,019 | 95,145 | 94,967 | |||||||||||||||||||
Weighted average shares outstanding – diluted | 96,104 | 95,702 | 95,902 | 95,471 | |||||||||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items5 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 2,366,161 | (2,207,527) | 158,634 | 6.7 | % | (129,135) | (1,809) | $ | 27,690 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 1,788 | — | 1,788 | |||||||||||||||||
Mark to market (gains) losses | — | (2,393) | (2,393) | — | — | (2,393) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (1,076) | (1,076) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (54) | (54) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | 544 | 544 | — | — | 544 | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 2,403 | 2,403 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 3,204 | — | 3,204 | |||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | |||||||||||||||||
Other items | — | 54 | 54 | — | — | 54 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 2,366,161 | (2,209,322) | 156,839 | 6.6 | % | (124,143) | (536) | $ | 32,160 | |||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items6 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 2,167,464 | (2,009,045) | 158,419 | 7.3 | % | (122,675) | (935) | $ | 34,809 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 1,776 | — | 1,776 | |||||||||||||||||
Mark to market (gains) losses | — | (378) | (378) | — | — | (378) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (90) | (90) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (472) | (472) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (187) | (187) | — | — | (187) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 740 | 740 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 459 | — | 459 | |||||||||||||||||
Other items | — | 11 | 11 | — | — | 11 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 2,167,464 | (2,009,599) | 157,865 | 7.3 | % | (120,440) | (757) | $ | 36,668 | |||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 4,876 | 3,900 | (15,202) | (21,821) | 7,362 | 6,805 | $ | (803) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 803 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 1,788 | — | ||||||||||||||||
Mark to market (gains) losses | (923) | — | — | — | — | (3,316) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (1,076) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (54) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | (5,482) | — | — | — | — | (4,938) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 2,403 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 3,204 | — | ||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | — | ||||||||||||||||
Other items | 2,224 | — | — | — | — | 2,278 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | (2,955) | (2,955) | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 17,386 | (48) | 17,338 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 695 | 3,900 | (15,202) | (4,435) | 4,359 | 21,477 | $ | — | ||||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 11,137 | 2,410 | (18,055) | (264) | (403) | 29,634 | $ | (61,231) | ||||||||||||||
Loss (income) from discontinued operations, net of income taxes | — | — | — | — | — | — | 61,231 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 1,776 | — | ||||||||||||||||
Mark to market losses | (10,978) | — | — | — | — | (11,356) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (90) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (472) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | — | — | — | — | — | (187) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 740 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 459 | — | ||||||||||||||||
Other items | — | — | — | — | — | 11 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | 7,926 | 7,926 | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | (5,240) | (98) | (5,338) | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 159 | 2,410 | (18,055) | (5,504) | 7,425 | 23,103 | $ | — | ||||||||||||||
Three Months Ended December 31, 2025 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 6,002 | (8,666) | $ | (2,664) | $ | (0.03) | |||||||
Loss from discontinued operations, net of income taxes | 803 | — | 803 | |||||||||||
Amortization of intangible assets | 1,788 | — | 1,788 | |||||||||||
Mark to market (gains) losses | (3,316) | — | (3,316) | |||||||||||
Gain on asset sales | (1,076) | — | (1,076) | |||||||||||
Gain on disposal of businesses | (54) | — | (54) | |||||||||||
Insurance proceeds, net of asset write-downs | (4,938) | — | (4,938) | |||||||||||
Impairment of property, plant and equipment and lease assets | 2,403 | — | 2,403 | |||||||||||
Restructuring and costs for legal matters | 3,204 | — | 3,204 | |||||||||||
Debt refinancing expenses | — | — | — | |||||||||||
Other items | 2,278 | — | 2,278 | |||||||||||
Adjustments from equity method investments | (2,955) | — | (2,955) | |||||||||||
Income tax on items above and discrete tax items | 17,338 | — | 17,338 | |||||||||||
NCI impact on items above | — | 978 | 978 | |||||||||||
Adjusted (Non-GAAP) | $ | 21,477 | (7,688) | $ | 13,789 | $ | 0.14 | |||||||
Weighted average shares outstanding – diluted | 96,104 | |||||||||||||
Three Months Ended December 31, 2024 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | (31,597) | (7,552) | $ | (39,149) | $ | (0.41) | |||||||
Loss from discontinued operations, net of income taxes | 61,231 | — | 61,231 | |||||||||||
Amortization of intangible assets | 1,776 | — | 1,776 | |||||||||||
Mark to market (gains) losses | (11,356) | — | (11,356) | |||||||||||
Gain on asset sales | (90) | — | (90) | |||||||||||
Gain on disposal of businesses | (472) | — | (472) | |||||||||||
Insurance proceeds, net of asset write-downs | (187) | — | (187) | |||||||||||
Impairment of property, plant and equipment and lease assets | 740 | — | 740 | |||||||||||
Restructuring and costs for legal matters | 459 | — | 459 | |||||||||||
Other items | 11 | — | 11 | |||||||||||
Adjustments from equity method investments | 7,926 | — | 7,926 | |||||||||||
Income tax on items above and discrete tax items | (5,338) | — | (5,338) | |||||||||||
NCI impact on items above | — | (271) | (271) | |||||||||||
Adjusted (Non-GAAP) | $ | 23,103 | (7,823) | $ | 15,280 | $ | 0.16 | |||||||
Weighted average shares outstanding – diluted | 95,702 | |||||||||||||
Year Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items7 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 9,172,907 | (8,458,599) | 714,308 | 7.8 | % | (495,476) | 4,133 | $ | 222,965 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 7,102 | — | 7,102 | |||||||||||||||||
Mark to market (gains) losses | — | (517) | (517) | — | — | (517) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (12,254) | (12,254) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (606) | (606) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (1,342) | (1,342) | — | — | (1,342) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 10,611 | 10,611 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 3,786 | — | 3,786 | |||||||||||||||||
Debt refinancing expenses | — | — | — | — | — | — | |||||||||||||||||
Other items | — | 226 | 226 | 130 | — | 356 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 9,172,907 | (8,460,232) | 712,675 | 7.8 | % | (484,458) | 1,884 | $ | 230,101 | |||||||||||||
Year Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Revenue, net | Cost of sales | Gross profit | Gross Margin % | Selling, marketing, general and administration expenses | Other operating items8 | Operating Income | |||||||||||||||||
Reported (GAAP) | $ | 8,475,343 | (7,757,622) | 717,721 | 8.5 | % | (474,058) | 36,901 | $ | 280,564 | |||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | |||||||||||||||||
Amortization of intangible assets | — | — | — | 7,556 | — | 7,556 | |||||||||||||||||
Mark to market (gains) losses | — | (228) | (228) | — | — | (228) | |||||||||||||||||
Gain on asset sales | — | — | — | — | (125) | (125) | |||||||||||||||||
Gain on disposal of businesses | — | — | — | — | (76,417) | (76,417) | |||||||||||||||||
Insurance proceeds, net of asset write-downs | — | (2,878) | (2,878) | — | — | (2,878) | |||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | 740 | 740 | |||||||||||||||||
Impairment of goodwill | — | — | — | — | 36,684 | 36,684 | |||||||||||||||||
Restructuring and costs for legal matters | — | — | — | 459 | — | 459 | |||||||||||||||||
Other items | — | 73 | 73 | — | — | 73 | |||||||||||||||||
Adjustments from equity method investments | — | — | — | — | — | — | |||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | — | — | — | |||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | |||||||||||||||||
Adjusted (Non-GAAP) | $ | 8,475,343 | (7,760,655) | 714,688 | 8.4 | % | (466,043) | (2,217) | $ | 246,428 | |||||||||||||
Year Ended December 31, 2025 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | (1,574) | 13,373 | (66,541) | (71,003) | 30,714 | 127,934 | $ | (45,959) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 45,959 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 7,102 | — | ||||||||||||||||
Mark to market (gains) losses | 19,270 | — | — | — | — | 18,753 | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (12,254) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (606) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | (15,470) | — | — | — | — | (16,812) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 10,611 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 3,786 | — | ||||||||||||||||
Debt refinancing expenses | 3,182 | — | — | — | — | 3,182 | — | ||||||||||||||||
Other items | 2,237 | — | — | — | — | 2,593 | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | (10,115) | (10,115) | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 12,258 | 588 | 12,846 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 7,645 | 13,373 | (66,541) | (58,745) | 21,187 | 147,020 | $ | — | ||||||||||||||
Year Ended December 31, 2024 (U.S. Dollars in thousands) | |||||||||||||||||||||||
Other income (expense), net | Interest income | Interest expense | Income tax expense | Equity earnings | Income from continuing operations | Loss from discontinued operations, net of income taxes | |||||||||||||||||
Reported (GAAP) | $ | 20,595 | 10,745 | (72,264) | (75,649) | 8,308 | 172,299 | $ | (28,880) | ||||||||||||||
Loss from discontinued operations, net of income taxes | — | — | — | — | — | — | 28,880 | ||||||||||||||||
Amortization of intangible assets | — | — | — | — | — | 7,556 | — | ||||||||||||||||
Mark to market (gains) losses | (9,911) | — | — | — | — | (10,139) | — | ||||||||||||||||
Gain on asset sales | — | — | — | — | — | (125) | — | ||||||||||||||||
Gain on disposal of businesses | — | — | — | — | — | (76,417) | — | ||||||||||||||||
Insurance proceeds, net of asset write-downs | — | — | — | — | — | (2,878) | — | ||||||||||||||||
Impairment of property, plant and equipment and lease assets | — | — | — | — | — | 740 | — | ||||||||||||||||
Impairment of goodwill | — | — | — | — | — | 36,684 | — | ||||||||||||||||
Restructuring and costs for legal matters | — | — | — | — | — | 459 | — | ||||||||||||||||
Other items | (80) | — | — | — | — | (7) | — | ||||||||||||||||
Adjustments from equity method investments | — | — | — | — | 9,708 | 9,708 | — | ||||||||||||||||
Income tax on items above and discrete tax items | — | — | — | 13,560 | (398) | 13,162 | — | ||||||||||||||||
NCI impact on items above | — | — | — | — | — | — | — | ||||||||||||||||
Adjusted (Non-GAAP) | $ | 10,604 | 10,745 | (72,264) | (62,089) | 17,618 | 151,042 | $ | — | ||||||||||||||
Year Ended December 31, 2025 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 81,975 | (30,656) | $ | 51,319 | $ | 0.54 | |||||||
Loss from discontinued operations, net of income taxes | 45,959 | — | 45,959 | |||||||||||
Amortization of intangible assets | 7,102 | — | 7,102 | |||||||||||
Mark to market (gains) losses | 18,753 | — | 18,753 | |||||||||||
Gain on asset sales | (12,254) | — | (12,254) | |||||||||||
Gain on disposal of businesses | (606) | — | (606) | |||||||||||
Insurance proceeds, net of asset write-downs | (16,812) | — | (16,812) | |||||||||||
Impairment of property, plant and equipment and lease assets | 10,611 | — | 10,611 | |||||||||||
Restructuring and costs for legal matters | 3,786 | — | 3,786 | |||||||||||
Debt refinancing expenses | 3,182 | — | 3,182 | |||||||||||
Other items | 2,593 | — | 2,593 | |||||||||||
Adjustments from equity method investments | (10,115) | — | (10,115) | |||||||||||
Income tax on items above and discrete tax items | 12,846 | — | 12,846 | |||||||||||
NCI impact on items above | — | (1,324) | (1,324) | |||||||||||
Adjusted (Non-GAAP) | $ | 147,020 | (31,980) | $ | 115,040 | $ | 1.20 | |||||||
Weighted average shares outstanding – diluted | 95,902 | |||||||||||||
Year Ended December 31, 2024 (U.S. Dollars and shares in thousands, except per share amounts) | ||||||||||||||
Net income (loss) | Net income attributable to noncontrolling interests | Net (loss) income attributable to Dole plc | Diluted net income per share | |||||||||||
Reported (GAAP) | $ | 143,419 | (17,906) | $ | 125,513 | $ | 1.31 | |||||||
Loss from discontinued operations, net of income taxes | 28,880 | — | 28,880 | |||||||||||
Amortization of intangible assets | 7,556 | — | 7,556 | |||||||||||
Mark to market (gains) losses | (10,139) | — | (10,139) | |||||||||||
Gain on asset sales | (125) | — | (125) | |||||||||||
Gain on disposal of business | (76,417) | — | (76,417) | |||||||||||
Insurance proceeds, net of asset write-downs | (2,878) | — | (2,878) | |||||||||||
Impairment of property, plant and equipment and lease assets | 740 | — | 740 | |||||||||||
Impairment of goodwill | 36,684 | — | 36,684 | |||||||||||
Restructuring and costs for legal matters | 459 | — | 459 | |||||||||||
Other items | (7) | — | (7) | |||||||||||
Adjustments from equity method investments | 9,708 | — | 9,708 | |||||||||||
Income tax on items above and discrete tax items | 13,162 | — | 13,162 | |||||||||||
NCI impact on items above | — | (12,239) | (12,239) | |||||||||||
Adjusted (Non-GAAP) | $ | 151,042 | (30,145) | $ | 120,897 | $ | 1.27 | |||||||
Weighted average shares outstanding – diluted | 95,471 | |||||||||||||
Revenue for the Three Months Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 819,066 | $ | 217 | $ | — | $ | 54,753 | $ | 874,036 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 910,604 | 76,978 | (3,015) | 41,320 | 1,025,887 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 463,285 | (58) | — | 23,228 | 486,455 | ||||||||||||||||||||||||
Intersegment | (25,491) | — | — | 5,275 | (20,216) | ||||||||||||||||||||||||
Total | $ | 2,167,464 | $ | 77,137 | $ | (3,015) | $ | 124,576 | $ | 2,366,162 | |||||||||||||||||||
Adjusted EBITDA for the Three Months Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 31,890 | $ | (382) | $ | 178 | $ | (5,084) | $ | 26,602 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 32,487 | 3,723 | (96) | (3,517) | 32,597 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 10,234 | (99) | (750) | 4,083 | 13,468 | ||||||||||||||||||||||||
Total | $ | 74,611 | $ | 3,242 | $ | (668) | $ | (4,518) | $ | 72,667 | |||||||||||||||||||
Revenue for the Year Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 3,293,527 | $ | 754 | $ | — | $ | 320,846 | $ | 3,615,127 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 3,608,692 | 171,992 | (31,678) | 267,567 | 4,016,573 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 1,686,281 | (3,388) | (79,307) | 52,621 | 1,656,207 | ||||||||||||||||||||||||
Intersegment | (113,157) | — | — | (1,843) | (115,000) | ||||||||||||||||||||||||
Total | $ | 8,475,343 | $ | 169,358 | $ | (110,985) | $ | 639,191 | $ | 9,172,907 | |||||||||||||||||||
Adjusted EBITDA for the Year Ended | |||||||||||||||||||||||||||||
December 31, 2024 | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | December 31, 2025 | |||||||||||||||||||||||||
(U.S. Dollars in thousands) | |||||||||||||||||||||||||||||
Fresh Fruit | $ | 214,848 | $ | (744) | $ | 565 | $ | (24,827) | $ | 189,842 | |||||||||||||||||||
Diversified Fresh Produce - EMEA | 131,504 | 8,349 | 42 | 10,086 | 149,981 | ||||||||||||||||||||||||
Diversified Fresh Produce - Americas & ROW | 45,851 | (451) | (2,724) | 12,877 | 55,553 | ||||||||||||||||||||||||
Total | $ | 392,203 | $ | 7,154 | $ | (2,117) | $ | (1,864) | $ | 395,376 | |||||||||||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
(U.S. Dollars in thousands) | |||||||||||
Cash and cash equivalents (Reported GAAP) | $ | 267,854 | $ | 330,017 | |||||||
Debt (Reported GAAP): | |||||||||||
Long-term debt, net | (799,814) | (866,075) | |||||||||
Current maturities | (57,668) | (80,097) | |||||||||
Bank overdrafts | (9,611) | (11,443) | |||||||||
Total debt, net | (867,093) | (957,615) | |||||||||
Less: Debt discounts and debt issuance costs (Reported GAAP) | (7,237) | (9,531) | |||||||||
Total gross debt | (874,330) | (967,146) | |||||||||
Net Debt (Non-GAAP) | $ | (606,476) | $ | (637,129) | |||||||
LTM Adjusted EBITDA (Non-GAAP) | 395,376 | 392,203 | |||||||||
Net Leverage (Non-GAAP) | 1.5x | 1.6x | |||||||||
Last Twelve Months ("LTM") Adjusted EBITDA | |||||||||||
FY'25 Adjusted EBITDA | 395,376 | 392,203 | |||||||||
LTM Adjusted EBITDA | $ | 395,376 | $ | 392,203 | |||||||
Year Ended | |||||||||||
December 31, 2025 | December 31, 2024 | ||||||||||
(U.S. Dollars in thousands) | |||||||||||
Net cash provided by operating activities - continuing operations (Reported GAAP) | $ | 123,206 | $ | 262,721 | |||||||
Less: Capital expenditures (Reported GAAP)9 | (121,497) | (82,435) | |||||||||
Free cash flow from continuing operations (Non-GAAP) | $ | 1,709 | $ | 180,286 | |||||||